Moderna | MRNA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Arrowhead Research USD 9.02B 4.25B 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Moderna USD 20.15B 8.53B 2026-03
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.79B 213.72M 2026-05
Qiagen NV USD 6.43B 1.85B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.26B 238M 2025-12
Sartorius EUR 14.25B 2.16B 2026-03
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05
Zealand Pharma A/S 33.35B 448.34M 2025-12